Reply to "Meta-analysis of astaxanthin supplementation on obesity, blood pressure, CRP, glycemic biomarkers, and lipid profile: Reanalysis is needed"

Xia W 1 , Tang N 1 , Kord-Varkaneh H 2 , Low TY 3 , Tan SC 3 , Wu X 4 Show all authors , Zhu Y 5

Affiliations 

  • 1 Department of Endocrinology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, 610072, China
  • 2 Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • 3 UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
  • 4 Heart Failure Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, 610072, China. Electronic address: wuwucat5455@sina.com
  • 5 Department of Endocrinology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, 610072, China. Electronic address: zhuying_2004@163.com
Pharmacol Res, 2021 01;163:105167.
PMID: 32860944 DOI: 10.1016/j.phrs.2020.105167

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications